ADVERTISEMENT

PI Industries - Another Year Of Robust Performance: Axis Securities

Revenue growth is expected to accelerate as newer products and the pharma business contributes more significantly, says the brokerage.

<div class="paragraphs"><p>Scientist testing a chemical solutions in test tubes in R&amp;D lab. (Source: freepik)</p></div>
Scientist testing a chemical solutions in test tubes in R&D lab. (Source: freepik)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More